X4 PHARMACEUTICALS INC (XFOR) Stock Cash Flow
NASDAQ:XFOR - Nasdaq - US98420X1037 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -37.45M | -101.17M | -93.87M | -88.70M | -62.13M | |||
| Depreciation Amortization | 796.00K | 419.00K | 510.00K | 500.00K | 350.00K | |||
| Change In Working Capital | 2.67M | 344.00K | 5.74M | -1.50M | -4.06M | |||
| Interest Paid | 7.77M | 4.60M | 3.01M | 2.91M | 2.10M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | -96.92M | 3.89M | 10.52M | 18.79M | 7.03M | |||
| OPERATING CASH FLOW | -130.90M | -96.51M | -77.10M | -70.91M | -58.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -7.33M | -60.00K | -100.00K | -620.00K | -1.36M | |||
| Other Investing Activity | 74.32M | -14.82M | N/A | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | 66.99M | -14.88M | -100.00K | -620.00K | -1.36M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 20.00M | 20.44M | -800.00K | 0.00 | 12.39M | |||
| Stock Issued/Repurchased | 294.00K | 68.71M | 122.84M | 74.25M | 280.00K | |||
| Other Financing Activity | 0.00 | -631.00K | -4.81M | 0.00 | -280.00K | |||
| FINANCING CASH FLOW | 20.29M | 88.52M | 117.23M | 74.25M | 12.39M | |||
| Exchange Rate Effect | -156.00K | 99.00K | -110.00K | -320.00K | 400.00K | |||
| CHANGE IN CASH | -43.77M | -22.78M | 39.92M | 2.40M | -47.39M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -130.90M | -96.51M | -77.10M | -70.91M | -58.82M | |||
| Capital Expenditure | -7.33M | -60.00K | -100.00K | -620.00K | -1.36M | |||
| FREE CASH FLOW | -138.23M | -96.57M | -77.20M | -71.53M | -60.18M | |||
All data in USD